Xilio Therapeutics XLO
NASDAQ XLO
$8.03 -0.40 (-4.74%)
At close: Oct 22, 2026 · 4:00 PM EDT

Xilio Therapeutics (XLO) Depreciation and Depletion (2020 - 2026)

Updated

Xilio Therapeutics (XLO) posted Depreciation and Depletion of $300,000 for Q2 2026, down 25.0% from $400,000 a year earlier and unchanged from the prior quarter.

Analysis

Xilio Therapeutics (XLO) Depreciation and Depletion (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation and Depletion at Xilio Therapeutics was $1.2 million, down 29.4% year-over-year; for FY2025, it was $1.5 million, down 6.3% from FY2024.

  • Annual Depreciation and Depletion shows a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
  • In prior years, Xilio Therapeutics' Depreciation and Depletion was $1.6 million in FY2024 (-11.1%), $1.8 million in FY2023 (+5.9%), $1.7 million in FY2022 (+21.4%) and $1.4 million in FY2021 (+27.3%).
  • Quarterly Depreciation and Depletion has run from a low of $300,000 in Q3 2021 to a high of $500,000 in Q1 2025 over five years.
  • On a year-over-year basis, Depreciation and Depletion has declined in each of the last four quarters, with an average decline of 13.8% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation and Depletion in the past five years was Q3 2022, with growth of 66.7%; the weakest was Q1 2026, with a decline of 40.0%.
  • According to Business Quant data, Depreciation and Depletion for the three prior quarters was $300,000 (Q1 2026), $300,000 (Q4 2025) and $300,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 194.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 98.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Xilio Therapeutics 155.82 Mn -371.85 Mn - 300,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Mar 31, 2026 300,000.00
Dec 31, 2025 300,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 500,000.00
Dec 31, 2024 400,000.00
Sep 30, 2024 400,000.00
Jun 30, 2024 400,000.00
Mar 31, 2024 400,000.00
Dec 31, 2023 400,000.00
Sep 30, 2023 500,000.00
Jun 30, 2023 400,000.00
Mar 31, 2023 500,000.00
Dec 31, 2022 400,000.00
Sep 30, 2022 500,000.00
Jun 30, 2022 400,000.00
Mar 31, 2022 400,000.00
Dec 31, 2021 400,000.00
Sep 30, 2021 300,000.00
API Access

Xilio Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=XLO&period=max&api_key=YOUR_API_KEY